| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.0105-2896.2005.00328.X |
| P698 | PubMed publication ID | 16313346 |
| P2093 | author name string | Mark C Horowitz | |
| David G Schatz | |||
| Alfred L M Bothwell | |||
| David G T Hesslein | |||
| David L Pflugh | |||
| P2860 | cites work | Commitment to the B-lymphoid lineage depends on the transcription factor Pax5 | Q22010683 |
| OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways | Q22011195 | ||
| A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins | Q24299387 | ||
| Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 | ||
| TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells | Q24315251 | ||
| Mutation of the mouse klotho gene leads to a syndrome resembling ageing | Q24328782 | ||
| A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
| Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival | Q28142897 | ||
| An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome | Q28181736 | ||
| Cloning and characterization of a promoter flanking the early B cell factor (EBF) gene indicates roles for E-proteins and autoregulation in the control of EBF expression | Q28206150 | ||
| E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements | Q28243194 | ||
| Structure and function of helix-loop-helix proteins | Q28244116 | ||
| Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region | Q28252666 | ||
| Molecular cloning of the olfactory neuronal transcription factor Olf-1 by genetic selection in yeast | Q28260090 | ||
| Insight into the microphthalmia gene | Q28274443 | ||
| The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor | Q28285539 | ||
| The helix-loop-helix gene E2A is required for B cell formation | Q28504830 | ||
| Bcl11a is essential for normal lymphoid development | Q28511014 | ||
| splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3 | Q28585890 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection | Q28592813 | ||
| The Ikaros gene is required for the development of all lymphoid lineages | Q28594316 | ||
| Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts | Q29547605 | ||
| Osteoblastic cells regulate the haematopoietic stem cell niche | Q29615007 | ||
| Identification of the haematopoietic stem cell niche and control of the niche size | Q29615008 | ||
| Mouse small eye results from mutations in a paired-like homeobox-containing gene | Q29617930 | ||
| Marrow stromal cells as stem cells for nonhematopoietic tissues | Q29618770 | ||
| Mesenchymal stem cells | Q29619804 | ||
| Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesis | Q33194891 | ||
| Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction | Q33886695 | ||
| PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors | Q33889234 | ||
| Human EVI9, a homologue of the mouse myeloid leukemia gene, is expressed in the hematopoietic progenitors and down-regulated during myeloid differentiation of HL60 cells | Q33931854 | ||
| Stepwise reprogramming of B cells into macrophages | Q33978638 | ||
| B cell development pathways | Q34178187 | ||
| Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. | Q50522916 | ||
| Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development. | Q51031105 | ||
| Connection between B lymphocyte and osteoclast differentiation pathways. | Q52130852 | ||
| Bipotential B-macrophage progenitors are present in adult bone marrow. | Q52137758 | ||
| Osteoblasts and The Hematopoietic Microenvironment. | Q52180946 | ||
| B-cell development: a comparison between mouse and man. | Q52182974 | ||
| Controls in patterning and diversification of somatic muscles during Drosophila embryogenesis. | Q52573428 | ||
| Impaired osteoclast differentiation in subcutaneous implants of bone particles in osteopetrotic mutants. | Q54358874 | ||
| Regulation of B lymphocyte and macrophage development by graded expression of PU.1. | Q55033922 | ||
| Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development | Q57339934 | ||
| Immunoglobulin heavy and light chain genes rearrange independently at early stages of B cell development | Q57339980 | ||
| Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP | Q58326934 | ||
| The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
| Factors and forces controlling V(D)J recombination | Q34296487 | ||
| The surrogate light chain in B-cell development. | Q34340103 | ||
| Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. | Q34469691 | ||
| Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density | Q35787208 | ||
| Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow | Q36230070 | ||
| Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through use of bone marrow and splenic transplants | Q36358419 | ||
| Delayed hematopoietic development in osteopetrotic (op/op) mice | Q36361203 | ||
| The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver | Q36362209 | ||
| Suppression of B lymphopoiesis during normal pregnancy | Q36362518 | ||
| Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice | Q36364066 | ||
| Defects in hemopoietic stem cell activity in Ikaros mutant mice | Q36375493 | ||
| Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors | Q36375584 | ||
| Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A | Q36402675 | ||
| Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis | Q36402845 | ||
| Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency | Q36566505 | ||
| Collier, a novel regulator of Drosophila head development, is expressed in a single mitotic domain | Q36818102 | ||
| Advances in bone biology: the osteoclast | Q36825193 | ||
| Failure of B-cell differentiation in mice lacking the transcription factor EBF. | Q38293381 | ||
| Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function | Q38525468 | ||
| Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin | Q39116155 | ||
| Early B-cell factor (O/E-1) is a promoter of adipogenesis and involved in control of genes important for terminal adipocyte differentiation. | Q39677760 | ||
| Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage | Q39958765 | ||
| Epigenetic silencing of the c-fms locus during B-lymphopoiesis occurs in discrete steps and is reversible. | Q40253222 | ||
| Pax5-deficient mice exhibit early onset osteopenia with increased osteoclast progenitors | Q40489394 | ||
| PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors | Q40747831 | ||
| Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells | Q40927574 | ||
| Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. | Q40937465 | ||
| STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroi | Q40945774 | ||
| EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes | Q41101434 | ||
| Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. | Q41121255 | ||
| Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo | Q41753607 | ||
| Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. | Q42064178 | ||
| Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor | Q42139985 | ||
| Olf-1/early B cell factor is a regulator of glut4 gene expression in 3T3-L1 adipocytes | Q42823980 | ||
| Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. | Q42826784 | ||
| The cell-surface form of colony-stimulating factor-1 is regulated by osteotropic agents and supports formation of multinucleated osteoclast-like cells. | Q42831612 | ||
| Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice | Q44124109 | ||
| The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors | Q44480297 | ||
| Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis | Q44514609 | ||
| Genetic disruptions of O/E2 and O/E3 genes reveal involvement in olfactory receptor neuron projection | Q48017039 | ||
| Family of Ebf/Olf-1-related genes potentially involved in neuronal differentiation and regional specification in the central nervous system | Q48042170 | ||
| Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene | Q48111435 | ||
| Conservation of a large protein domain in the segmentation gene paired and in functionally related genes of Drosophila. | Q48354415 | ||
| P921 | main subject | osteoblast | Q917177 |
| P304 | page(s) | 141-153 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | B cells and osteoblast and osteoclast development | |
| P478 | volume | 208 |
| Q53190419 | Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG. |
| Q37671125 | Bone mineral metabolism and subsequent hospitalization with poor quality of life in dialysis patients |
| Q46114690 | Bony Immunology: 1st Annual International Conference on Osteoimmunology Crete, Greece, May 28–June 2, 2006. |
| Q57463380 | Clinical immunity in bone and joints |
| Q33952238 | Daidzein prevents the increase in CD4+CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect |
| Q90265843 | Disruption of the preB Cell Receptor Complex Leads to Decreased Bone Mass |
| Q90232648 | Dual effects of baicalin on osteoclast differentiation and bone resorption |
| Q37133899 | Ebf1-dependent control of the osteoblast and adipocyte lineages |
| Q53060269 | Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies. |
| Q36323192 | Examination of ERα signaling pathways in bone of mutant mouse models reveals the importance of ERE-dependent signaling |
| Q36331891 | Functional relevance for associations between osteoporosis and genetic variants |
| Q47253343 | Generation of an osteoblast-based artificial niche that supports in vitro B lymphopoiesis. |
| Q47877538 | Interleukin 27 (IL-27) Alleviates Bone Loss in Estrogen-deficient Conditions by Induction of Early Growth Response-2 Gene |
| Q37172974 | Marrow fat and the bone microenvironment: developmental, functional, and pathological implications |
| Q37921954 | Mesenchymal niches of bone marrow in cancer |
| Q36285002 | Multiple quantitative trait loci for cortical and trabecular bone regulation map to mid-distal mouse chromosome 4 that shares linkage homology to human chromosome 1p36 |
| Q45323711 | Osteoblasts Are Rapidly Ablated by Virus-Induced Systemic Inflammation following Lymphocytic Choriomeningitis Virus or Pneumonia Virus of Mice Infection in Mice |
| Q36942525 | Osteoimmunology: a view from the bone |
| Q90372125 | Prognostic impact of preoperative serum alkaline phosphatase level on a composite of morbidity and mortality after thoracic endovascular aortic repair: A retrospective study |
| Q35191573 | Resolving the Two "Bony" Faces of PPAR-gamma. |
| Q39733993 | Retinoid-suppressed phosphorylation of RARalpha mediates the differentiation pathway of osteosarcoma cells |
| Q36054302 | Serum Alkaline Phosphatase Levels Predict Infection-Related Mortality and Hospitalization in Peritoneal Dialysis Patients |
| Q33888428 | Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization |
| Q37125989 | Strain-specific effects of rosiglitazone on bone mass, body composition, and serum insulin-like growth factor-I |
| Q50523565 | Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis. |
| Q37997073 | Tec family kinases in inflammation and disease |
| Q37287589 | The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis |
| Q36593298 | The role of osteocytes and bone microstructure in preventing osteoporotic fractures |
| Q36467113 | The stem cell niches in bone |
| Q38979293 | Vitamin D Level Between Calcium-Phosphorus Homeostasis and Immune System: New Perspective in Osteoporosis. |
Search more.